Credit Suisse’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $649K | Sell |
18,561
-1,181
| -6% | -$41.3K | ﹤0.01% | 2509 |
|
|
2023
Q4 | $750K | Sell |
19,742
-3,167
| -14% | -$120K | ﹤0.01% | 2516 |
|
|
2023
Q3 | $420K | Sell |
22,909
-6,494
| -22% | -$119K | ﹤0.01% | 2761 |
|
|
2023
Q2 | $763K | Buy |
29,403
+9,013
| +44% | +$234K | ﹤0.01% | 2552 |
|
|
2023
Q1 | $385K | Buy |
20,390
+1,274
| +7% | +$24K | ﹤0.01% | 2870 |
|
|
2022
Q4 | $471K | Sell |
19,116
-810
| -4% | -$20K | ﹤0.01% | 2810 |
|
|
2022
Q3 | $358K | Buy |
19,926
+7,966
| +67% | +$143K | ﹤0.01% | 2976 |
|
|
2022
Q2 | $136K | Buy |
+11,960
| New | +$136K | ﹤0.01% | 3440 |
|
|
2022
Q1 | – | Sell |
-7,220
| Closed | -$315K | – | 3720 |
|
|
2021
Q4 | $315K | Buy |
+7,220
| New | +$315K | ﹤0.01% | 3284 |
|